Shares of Cohance Lifesciences surged 20% on Monday after the appointment of former Cipla CEO Umang Vohra as its new Executive Chairman and Group CEO. His leadership is expected to drive transformation, scale operations, and strengthen global partnerships as the company enters its next growth phase.